Aurobindo obtains last approval from US FDA on generic drug

Aurobindo Pharma obtain a last nod from the US Food & Drug Administration (US FDA) to produce and market generic drug, Piperacillin and Tazobactam injection of changeable strength packed in single use vials, according to the firm in a press release on Tuesday.